Zhang Yi, Wang Li-Juan, Li Wei-Feng, Zhang Xu, Yang Xian-Jin
Department of General Surgery, the First People's Hospital of Neijiang, Neijiang, Sichuan Province Department of Nephrology, ShangRao People 's Hospital, ShangRao Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, P. R. China.
Medicine (Baltimore). 2018 Jun;97(26):e11139. doi: 10.1097/MD.0000000000011139.
Increased expression of HOX transcription antisense RNA (HOTAIR) has been reported to be associated with unfavorable prognosis in cancer patients. Several studies have evaluated the significance of HOTAIR in the development and progression of gastrointestinal cancers (GICs).
Systematic literature retrieval was performed by searching keywords in several electronic databases, including PubMed, Embase, Web of Science, CNKI, Springer, Google Scholar, and GEO. Relevant articles on association between HOTAIR expression levels and prognosis in patients with GIC were collected and screened with eligible criteria. The RevMan 5.2 software and Stata SE12.0 software was applied.
A total of 1297 patients from 15 eligible articles were included in this meta-analysis. The results revealed that increased expression of HOTAIR was significantly associated with shorter overall survival (OS) in GIC patients [hazard ratio (HR) = 1.93, 95% CI: 1.64-2.26], as well as poorer disease-free survival (DFS) (HR = 2.79; 95% CI: 1.38-5.63). Additionally, the pooled odds ratio (OR) indicated that increased HOTAIR was associated with clinicopathological parameters, including lymph node metastasis (OR = 2.48, 95% CI: 1.71-3.61), distant metastasis (OR = 4.34, 95% CI: 2.12-8.91), poor tumor differentiation (OR = 2.90, 95% CI: 1.45-5.80), lymphovascular invasion (OR = 2.86, 95% CI: 1.83-4.46), high depth of tumor invasion (OR = 2.07, 95% CI: 1.36-3.16), and poor clinical stage (OR = 2.72, 95% CI: 1.70-4.35). In survival analysis through the Kaplan-Meier plotter database, enhanced level of HOTAIR was associated with better OS and DFS in gastric cancer patients.
High expression level of HOTAIR was related to poor clinical outcome of GIC patients. The HOTAIR could be applied as potential biomarker for assessing the prognosis. Further well-designed studies should be performed to verify the clinical applications of HOTAIR in GIC.
据报道,HOX转录反义RNA(HOTAIR)表达增加与癌症患者的不良预后相关。多项研究评估了HOTAIR在胃肠道癌(GIC)发生发展中的意义。
通过在多个电子数据库中搜索关键词进行系统文献检索,这些数据库包括PubMed、Embase、Web of Science、CNKI、Springer、Google Scholar和GEO。收集并筛选符合纳入标准的关于GIC患者中HOTAIR表达水平与预后相关性的相关文章。应用RevMan 5.2软件和Stata SE12.0软件。
本荟萃分析共纳入了来自15篇符合条件文章的1297例患者。结果显示,HOTAIR表达增加与GIC患者较短的总生存期(OS)显著相关[风险比(HR)=1.93,95%置信区间(CI):1.64 - 2.26],以及较差的无病生存期(DFS)(HR = 2.79;95% CI:1.38 - 5.63)。此外,合并优势比(OR)表明,HOTAIR增加与临床病理参数相关,包括淋巴结转移(OR = 2.48,95% CI:1.71 - 3.61)、远处转移(OR = 4.34,95% CI:2.12 - 8.91)、肿瘤分化差(OR = 2.90,95% CI:1.45 - 5.80)、淋巴管侵犯(OR = 2.86,95% CI:1.83 - 4.46)、肿瘤浸润深度高(OR = 2.07,95% CI:1.36 - 3.16)和临床分期差(OR = 2.72,95% CI:1.70 - 4.35)。通过Kaplan-Meier绘图仪数据库进行的生存分析显示,HOTAIR水平升高与胃癌患者较好的OS和DFS相关。
HOTAIR高表达水平与GIC患者的不良临床结局相关。HOTAIR可作为评估预后的潜在生物标志物。应开展进一步设计良好的研究以验证HOTAIR在GIC中的临床应用。